You have 9 free searches left this month | for more free features.

dabigatran

Showing 26 - 50 of 495

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Medicines That Help in Thinning Blood in People With Atrial

Not yet recruiting
  • Atrial Fibrillation
  • No OAC
  • +4 more
  • (no location specified)
Apr 28, 2023

Venous Thromboembolism, Varicose Veins Trial in London (Dalteparin Sodium, Tinzaparin Sodium, Enoxaparin Sodium)

Not yet recruiting
  • Venous Thromboembolism
  • Varicose Veins
  • Dalteparin Sodium
  • +5 more
  • London, United Kingdom
    Imperial College Hospital NHS Foundation Trust
Feb 20, 2023

Oral Anticoagulation Drugs and How Well These Drugs Work in Real

Active, not recruiting
  • Atrial Fibrillation
  • Rivaroxaban (Xarelto)
  • +3 more
  • Multiple Locations, Sweden
    Many locations
Jan 20, 2023

Coronary Artery Disease, Myocardial Ischemia, Myocardial Infarction Trial in Heerlen (Dabigatran + Ticagrelor, Dabigatran +

Recruiting
  • Coronary Artery Disease
  • +3 more
  • Dabigatran + Ticagrelor
  • Dabigatran + clopidogrel
  • Heerlen, Limburg, Netherlands
    Zuyderland MC
Apr 29, 2021

Drug-Drug Interaction Trial in Porto (ITF2357 Givinostat 10mg/mL, Midazolam 1Mg/Ml (Pf) Inj Syringe 5Ml, Midazolam Oral Liquid

Completed
  • Drug-Drug Interaction
  • ITF2357 Givinostat 10mg/mL
  • +4 more
  • Porto, Portugal
    Hospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
Aug 4, 2022

Find Out Whether Education Improves Adherence to Dabigatran in

Active, not recruiting
  • Atrial Fibrillation
  • Dabigatran
  • Chia-Yi City, Taiwan
  • +22 more
Jan 9, 2023

Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)

Recruiting
  • Bleeding Post Cardiac Surgery
  • Indication for Anticoagulation
  • Hamilton, Ontario, Canada
    Hamilton General Hospital
Oct 31, 2022

Healthy Subjects, Drug-drug Interaction, Pharmacokinetics Trial in San Antonio (Dabigatran Etexilate Mesylate, Quizartinib)

Completed
  • Healthy Subjects
  • +3 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Jun 16, 2021

Healthy Trial in Singapore (Lasmiditan, Dabigatran Etexilate, Rosuvastatin)

Completed
  • Healthy
  • Singapore, Singapore
    Lilly Centre for Clinical Pharmacology
Jul 16, 2021

Healthy Trial in Merksem (Dabigatran Etexilate, DRV/COBI, Ritonavir)

Completed
  • Healthy
  • Dabigatran Etexilate
  • +3 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jun 8, 2021

Atrial Fibrillation, Antithrombotic Therapy, Acute Coronary Syndrome Trial in Gdansk (Ticagrelor, Dabigatran Etexilate, Aspirin)

Recruiting
  • Atrial Fibrillation
  • +3 more
  • Gdańsk, Pomorskie, Poland
    Cardiac lntensive Care Unit, First Department of Cardiology, Uni
Oct 27, 2021

Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)

Recruiting
  • Atrial Fibrillation
  • Recurrent Venous Thromboembolism
  • dabigatran, rivaroxaban, apixaban or edoxaban
  • Barcelona, Catalonia, Spain
    Hospital de la Santa Creu i Sant Pau
Apr 27, 2022

Japanese Pradaxa PMS, Long Term

Completed
  • Atrial Fibrillation
  • Prazaxa® Capsules
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd
Feb 3, 2022

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs

Completed
  • Venous Thromboembolism
  • Anticoagulants and Bleeding Disorders
  • Oral Anticoagulant
  • Oakland, California
  • +1 more
Oct 31, 2022

New Oral Anticoagulants in Treatment of Non-valvular Atrial

Recruiting
  • Atrial Fibrillation
  • Burgos, Spain
  • +5 more
Jan 2, 2023

Direct Oral AntiCoagulants and Ticagrelor Study II

Not yet recruiting
  • Novel Oral Anticoagulants
  • +11 more
  • Detection of genotype and RNA profile in platelet and white blood cell
  • +2 more
  • Hefei, Anhui, China
  • +5 more
Mar 1, 2023

Stroke and Systemic Embolism in Atrial Fibrillation in Real-Life

Completed
  • Anticoagulation
  • Rueil-malmaison Cedex, France
    (unnamed)
May 16, 2022

Anticoagulants in Patients With Venous Thromboembolism in Korea

Completed
  • Venous Thromboembolism
  • Parenteral anticoagulant
  • +5 more
  • Seongnam-si, Korea, Republic of
  • +1 more
May 20, 2022

Atrial Fibrillation, T2DM (Type 2 Diabetes), Chronic Kidney Diseases Trial in Moscow (Dabigatran Etexilate)

Recruiting
  • Atrial Fibrillation
  • +2 more
  • Dabigatran Etexilate
  • Moscow, Russian Federation
    I.M.Sechenov First Moscow State Medical University (Sechenov Uni
Mar 23, 2021

Left Atrial Appendage Closure, Thrombosis, Stroke Trial in Quebec (Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel

Recruiting
  • Left Atrial Appendage Closure
  • +4 more
  • Rivaroxaban, dabigatran, apixaban, or edoxaban
  • +2 more
  • Quebec, Canada
    Josep Rodes-Cabau
Jul 12, 2022

Prognosis of Ischemic Stroke Due to Large-artery Atherosclerosis

Recruiting
  • Ischemic Stroke
  • Large-Artery Atherosclerosis (Embolus/Thrombosis)
  • carotid artery stenting
  • +6 more
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 31, 2022

Venous Thrombosis, Tumors Trial in Minneapolis, Columbus, Milwaukee (Heparin, Low-Molecular-Weight, or direct oral

Completed
  • Venous Thrombosis
  • Neoplasms
  • Heparin, Low-Molecular-Weight, or direct oral anticoagulants
  • Minneapolis, Minnesota
  • +2 more
Apr 26, 2022

The DARE Warfarin CER Study

Enrolling by invitation
  • Deep Venous Thrombosis
  • Pulmonary Embolism
  • Dabigatran: extended treatment (e.g at least 90 days)
  • +14 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 17, 2021

Atrial Fibrillation, Mitral Stenosis Trial in Hong Kong (Dabigatran etexilate, Warfarin)

Recruiting
  • Atrial Fibrillation
  • Mitral Stenosis
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Nov 24, 2020

Atrial Fibrillation, Valve Heart Disease Trial in Seoul (Dabigatran, Acetylsalicylic acid, Warfarin)

Completed
  • Atrial Fibrillation
  • Valve Heart Disease
  • Dabigatran
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 11, 2021